Rifloxin - Rifloxin is a drug used to treat bacterial infections. It is a second generation fluoroquinolone antibacterial. It kills bacteria by interfering with the enzymes that cause DNA to rewind after being copied, which stops DNA and protein synthesis.
Rifloxin is marketed worldwide with over three hundred different brand names. In the United States, Canada and the UK, it is marketed as Ciloxan, Cipro, Cipro XR, Cipro XL Ciproxin and, most recently, Proquin. In Mexico it is available over the counter and marketed under the names Ciproflox or Ciprofloxacino. In Ecuador it is available and marketed under the name Cidrax. In Nigeria it is sold as Ciprotab while in Bangladesh it is marketed as Tablets and Microcapsules for Suspension by numerous companies, one of which is by Edruc Limited as Cipron. Additionally, Rifloxin is available as a generic drug under a variety of different brand names and is also available for limited use in veterinary medicine.
Rifloxin was first patented in 1983 by Bayer A.G. and subsequently approved by the United States Food and Drug Administration (FDA) in 1987.Ciprofloxacin has 12 F.D.A.-approved human uses and other veterinary uses, but it is often used for non-approved uses (off-label).
Rifloxin interacts with other drugs, herbal and natural supplements, and thyroid medications.
Rifloxin is an antibiotic. It is used to treat certain bacterial infections of the nose, lungs, skin, bones, joints, genitals, bladder and the digestive system. Rifloxin is also used to treat certain sexually transmitted diseases (STD). Rifloxin belongs to a group of antibiotics called the quinolones.